Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 3.1.1.4 - phospholipase A2 and Organism(s) Naja naja and UniProt Accession P15445

for references in articles please use BRENDA:EC3.1.1.4
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
     3 Hydrolases
         3.1 Acting on ester bonds
             3.1.1 Carboxylic-ester hydrolases
                3.1.1.4 phospholipase A2
IUBMB Comments
Also acts on phosphatidylethanolamine, choline plasmalogen and phosphatides, removing the fatty acid attached to the 2-position. Requires Ca2+.
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Naja naja
UNIPROT: P15445
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Naja naja
The enzyme appears in selected viruses and cellular organisms
Synonyms
phospholipase a2, cpla2, spla2, spla(2), prdx6, cytosolic phospholipase a2, crotoxin, pla2s, ipla2, spla2-iia, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
secretory phospholipase A2
-
14 kDa phospholipase A2
-
-
-
-
Agkistrotoxin
-
-
-
-
amdI1
-
-
-
-
Ammodytin I2
-
-
-
-
APLA
-
-
-
-
APP-D-49
-
-
-
-
ASPLA1
-
-
-
-
ASPLA10
-
-
-
-
ASPLA11
-
-
-
-
ASPLA12
-
-
-
-
ASPLA13
-
-
-
-
ASPLA14
-
-
-
-
ASPLA15
-
-
-
-
ASPLA16
-
-
-
-
ASPLA17
-
-
-
-
ASPLA2
-
-
-
-
ASPLA3
-
-
-
-
ASPLA4
-
-
-
-
ASPLA5
-
-
-
-
ASPLA6
-
-
-
-
ASPLA7
-
-
-
-
ASPLA8
-
-
-
-
ASPLA9
-
-
-
-
ATX
-
-
-
-
Basic protein I/II
-
-
-
-
BJ-PLA2
-
-
-
-
BJUPLA2
-
-
-
-
BPI/BPII
-
-
-
-
Ca2+-independent iPLA2
-
-
CaI-PLA2
-
-
-
-
Caudoxin
-
-
-
-
cPm09
-
-
-
-
cytosolic cPLA2
-
-
Enhancing factor
-
-
-
-
GIA cobra venom PLA2
-
-
GIIC sPLA2
-
-
-
-
GIID sPLA2
-
-
-
-
GIIE sPLA2
-
-
-
-
GIIF sPLA2
-
-
-
-
GIII sPLA2
-
-
-
-
group IA PLA2
-
-
Group IB phospholipase A2
-
-
-
-
Group IIA phospholipase A2
-
-
-
-
Group V phospholipase A2
-
-
-
-
Group VI phospholipase A2
-
-
-
-
GVI PLA2
-
-
-
-
GX sPLA2
-
-
-
-
GXII sPLA2
-
-
-
-
GXIII sPLA2
-
-
-
-
iPLA2
-
-
-
-
lecithinase A
-
-
-
-
MP-III 4R
-
-
-
-
Muscarinic inhibitor
-
-
-
-
Myotoxin
-
-
-
-
NAJPLA-2A
-
-
-
-
NAJPLA-2B
-
-
-
-
NAJPLA-2C
-
-
-
-
Nigexine
-
-
-
-
NN-X-PLA2
-
-
NN-XI-PLA2
-
-
NN-XIa-PLA2
-
-
NND-IV-PLA2
-
-
Non-pancreatic secretory phospholipase A2
-
-
-
-
Notechis 11'2
-
-
-
-
Notexin
-
-
-
-
NPLA
-
-
-
-
NPS-PLA2
-
-
-
-
OHV A-PLA2
-
-
-
-
OHV-APLA2
-
-
-
-
pgPLA 1a/pgPLA 2a
-
-
-
-
phosphatidase
-
-
-
-
phosphatide 2-acylhydrolase
-
-
-
-
phosphatidolipase
-
-
-
-
Phosphatidylcholine 2-acylhydrolase
-
-
-
-
Phosphatidylcholine 2-acylhydrolase GIIC
-
-
-
-
Phosphatidylcholine 2-acylhydrolase GIID
-
-
-
-
Phosphatidylcholine 2-acylhydrolase GIIE
-
-
-
-
Phosphatidylcholine 2-acylhydrolase GIIF
-
-
-
-
Phosphatidylcholine 2-acylhydrolase GIII
-
-
-
-
Phosphatidylcholine 2-acylhydrolase GX
-
-
-
-
Phosphatidylcholine 2-acylhydrolase GXII
-
-
-
-
Phosphatidylcholine 2-acylhydrolase GXIII
-
-
-
-
phospholipase A
-
-
-
-
phospholipase A2
-
-
Phospholipase A2 inhibitor
-
-
-
-
pkP5
-
-
-
-
PLA2-10
-
-
-
-
PLA2-VI
-
-
-
-
PLA2-VII
-
-
-
-
PLA2IID
-
-
-
-
platelet activating factor acetyl hydrolase
-
-
-
-
Pt-PLA1
-
-
-
-
Pt-PLA2
-
-
-
-
secreted sPLA2
-
-
secretory phospholipase A2
-
-
Secretory-type PLA, stroma-associated homolog
-
-
-
-
sPLA(2)-IID
-
-
-
-
sPLA(2)-IIE
-
-
-
-
sPLA(2)-IIF
-
-
-
-
sPLA2
-
-
TMV-K49
-
-
-
-
Toxin VI
-
-
-
-
Toxin VI:5
-
-
-
-
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
hydrolysis of carboxylic ester
-
-
-
-
SYSTEMATIC NAME
IUBMB Comments
phosphatidylcholine 2-acylhydrolase
Also acts on phosphatidylethanolamine, choline plasmalogen and phosphatides, removing the fatty acid attached to the 2-position. Requires Ca2+.
CAS REGISTRY NUMBER
COMMENTARY hide
9001-84-7
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
1,2-diacyl-sn-glycero-3-phosphorylcholine + H2O
1-acyl-sn-glycero-3-phosphorylcholine + fatty acid
show the reaction diagram
-
-
-
?
1,2-dimyristol-sn-glycero-phosphomethanol lithium salt + H2O
myristic acid + 1-myristoyl-sn-glycerophosphomethanol
show the reaction diagram
-
-
-
?
1-palmitoyl-2-(12-(3-(4-hydroxyphenyl)propionyl)amino dodecanoyl)phosphatidylcholine + H2O
1-palmitoyl-sn-glycerophosphorylcholine + 12-(3-(4-hydroxyphenyl)propionyl)amino dodecanoate
show the reaction diagram
-
-
-
-
?
phosphatidylcholine + H2O
1-acylglycerophosphocholine + fatty acid
show the reaction diagram
-
-
-
-
?
phosphatidylcholine + H2O
lysophosphatidylcholine + a fatty acid
show the reaction diagram
-
-
-
-
?
phosphatidylethanolamine + H2O
1-acylglycerophosphorylethanolamine + fatty acid
show the reaction diagram
-
-
-
?
phosphatidylserine + H2O
1-acylglycerophosphoserine + fatty acid
show the reaction diagram
-
-
-
?
phospholipids + H2O
?
show the reaction diagram
-
-
-
-
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
phosphatidylcholine + H2O
lysophosphatidylcholine + a fatty acid
show the reaction diagram
-
-
-
-
?
phospholipids + H2O
?
show the reaction diagram
-
-
-
-
?
additional information
?
-
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
minocycline
interferes with the conformation of the active-site Ca2+-binding loop, preventing Ca2+ binding, and shields the active site from substrate entrance, resulting in inhibition of the enzyme. Dissociation constant for PLA2 is Kd = 0.00018 M
1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol
-
MJ33, competitive inhibitor
3-[4'-(hydroxyimino-p-tolyl-methyl)-phenyl]-4-phenyl-sydnone
-
in vivo edema inducing activity, overview
3-[4'-(hydroxyimino-p-tolyl-methyl)-phenyl]-sydnone
-
in vivo edema inducing activity, overview
3-[4'-(hydroxyimino-phenyl-methyl)-phenyl]-4-phenyl-sydnone
-
in vivo edema inducing activity, overview
3-[4'-(hydroxyimino-phenyl-methyl)-phenyl]-sydnone
-
in vivo edema inducing activity, overview
3-[4-[hydroxyimino-(4'-n-butyl-phenyl)-methyl]-phenyl]-4-phenyl-sydnone
-
in vivo edema inducing activity, overview
3-[4-[hydroxyimino-(4'-n-butyl-phenyl)-methyl]-phenyl]-sydnone
-
in vivo edema inducing activity, overview
3-[4-[hydroxyimino-(4'-n-propyl-phenyl)-methyl]-phenyl]-4-phenylsydnone
-
in vivo edema inducing activity, overview
3-[4-[hydroxyimino-(4'-n-propyl-phenyl)-methyl]-phenyl]-sydnone
-
in vivo edema inducing activity, overview
Acetic anhydride
-
loss of both enzymatic and toxic properties
aristolochic acid
Ba2+
-
-
luffariellin B
-
-
manoalogue
-
synthetic analogue of the sea sponge-derived manoalide, time dependent irreversible loss of activity: modification of lysine residues
methyl arachidonyl fluorophosphonate
-
almost complete inhibition
omega-bromo-4-nitroacetophenone
-
-
p-bromophenacyl bromide
Sr2+
-
competitive inhibition
turmerin
-
inhibits the enzymatic activity and neutralises the pharmacological properties, such as cytotoxicity, oedema and myotoxicity of multitoxic phospholipase A2 of cobra venom in a dose-dependent manner, at a 1:2.5 molar ratio of PLA2:turmerin
Withania somnifera glycoprotein WSG
-
in molar ratio of 1:2, enzyme:WSG, complete inhibition of activity, but not neutralization of toxicity
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
phosphatidylcholine
-
activates hydrolysis of phosphatidylethanolamine
sphingomyelin
-
activates hydrolysis of phosphatidylethanolamine
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.19
1-palmitoyl-2-(12-(3-(4-hydroxyphenyl)propionyl)amino dodecanoyl)phosphatidylcholine
-
pH 8.5, 30°C
2 - 5
phosphatidylcholine
-
Triton X-100/phospholipid: 2/1
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
1100
-
phospholipid/Triton X-100: 1/4
1129
-
substrate: 1,2-diacyl-phosphatidylcholine
123
-
isoform NN-XI-PLA2, 37°C
138
-
isoform NN-XIa-PLA2, 37°C
1670
-
phospholipid/Triton X-100: 1/3
2000
-
Triton X-100/phospholipid: 2/1
2100
-
phospholipid/Triton X-100: 1/2
34
-
pH 7.5
additional information
-
sensitive activity assay using radioiodinatable long-chain phosphatidylcholine, detection limit is 0.25 ng enzyme or 0.05 ng substrate
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
7.5
-
indirect hemolytic assay at
8
-
enzymatic assay at
pH RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
7 - 9
-
substrate: 1,2-diacyl-phosphatidylcholine
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
37
-
assay at
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
physiological function
-
PLA2 induces cytotoxic effect on human peripheral lymphocytes. Increased creatine kinase levels (myonecrosis) in the group of mice treated with PLA2
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
PA2A2_NAJNA
119
0
13346
Swiss-Prot
other Location (Reliability: 3)
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
10000
-
x * 10000, SDS-PAGE
13000
-
gel filtration, SDS-PAGE, analytical ultracentrifugation
13262
-
x * 13262, MALDI-MS
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
trimer
dimer
-
2 * 13000, identical subunits, gel filtration, SDS-PAGE, analytical ultracentifugation, dimerization occurs at enzyme concentrations between 0.1 and 2 mg PLA2 per ml
monomer
polymer
-
13000, identical subunits, gel filtration, SDS-PAGE, analytical ultracentifugation, polimerization at enzyme concentrations above 5mg PLA2 per ml
trimer
-
observed in crystal, no data concerning MW
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
PLA2 in complex with inhibitor minocycline, by hanging drop vapor diffusion method, at 1.65 A resolution. Belongs to space group P213 with unit cell parameters a = 68.712 A, b = 68.712 A, c = 68.712 A. Minocycline binds to the hydrophobic cleft at the entrance of the active site of PLA2. As a consequence, the access of substrate molecules to the active site is blocked, and the conformation of the Ca2+-binding loop is stabilized in the Ca2+-free conformation of the apo-enzyme, thus resulting in inhibition of enzymatic activity. Interaction between PLA2 and minocycline is mainly hydrophobic
two crystal forms, cubic crystal: 1.8 A resolution and R-factor of 17%, orthorhombic form: 2.65 A resolution and R-factor of 21%
x-ray crystal structure, 6.0-2.3 A resolution, R-factor of 0.174, 148 water molecules included
-
TEMPERATURE STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
100
-
for 10 min at pH 3-4, only 5% loss in activity
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
guanidine-HCL, PLA2 retains 60% of activity when assay contains 6 M of guanidine-HCl
-
ORGANIC SOLVENT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Acetone
-
PLA2 regains almost full activity when added to assay mixture
benzene
-
PLA2 regains almost full activity when added to assay mixture
chloroform
-
PLA2 regains almost full activity when added to assay mixture
ether
-
PLA2 regains almost full activity when added to assay mixture
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
-20°C
-
4°C, pH 7.5, 0.05 M sodium phosphate buffer, no loss of activity over a period of several months
-
frozen, PLA2 concentration below 2 mg/ml, no loss of activity or precipitation for up to 12 months
-
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
by centrifugation and on anion-exchange column
by gel filtration
-
column chromatography, 15fold
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
PLA2 injected (subcutaneous) into the right hind paw of mice
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
drug development
applicability of minocycline as a lead compound for the design of specific inhibitors of PLA2, which play a crucial role in inflammatory processes
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Ghomashchi, F.; Yu, B.Z.; Mihelich, E.D.; Jain, M.K.; Gelb, M.H.
Kinetic characterization of phospholipase A2 modified by manoalogue
Biochemistry
30
9559-9569
1991
Apis mellifera, Naja naja, Sus scrofa
Manually annotated by BRENDA team
Hoffman, W.J.; Vahey, M.; Hajdu, J.
Pancreatic porcine phospholipase A2 catalyzed hydrolysis of phosphatidylcholine in lecithin-bile salt mixed micelles: Kinetic studies in a lecithin-sodium cholate system
Arch. Biochem. Biophys.
221
361-370
1983
Naja naja, Sus scrofa
Manually annotated by BRENDA team
Deems, R.A.; Dennis, E.A.
Phospholipase A2 from cobra venom (Naja naja naja)
Methods Enzymol.
71
703-710
1981
Naja naja
Manually annotated by BRENDA team
Segelke, B.W.; Nguyen, D.; Chee, R.; Xuong, N.H.; Dennis, E.A.
Structures of two novel crystal forms of Naja naja naja phospholipase A2 lacking Ca2+ reveal trimeric packing
J. Mol. Biol.
279
223-232
1998
Naja naja (P15445), Naja naja
Manually annotated by BRENDA team
Fremont, D.H.; Anderson, D.H.; Wilson, I.A.; Dennis, E.A.; Xuong, N.H.
Crystal structure of phospholipase A2 from Indian cobra reveals a trimeric association
Proc. Natl. Acad. Sci. USA
90
342-346
1993
Naja naja
Manually annotated by BRENDA team
Sundell, I.B.; Aziz, K.A.; Zuzel, M.; Theakston, R.D.G.
The role of phospholipases A2 in the stimulation of neutrophil motility by cobra venoms
Toxicon
41
459-468
2003
Naja naja, Naja mossambica
Manually annotated by BRENDA team
Caramelo, J.J.; Delfino, J.M.
A subnanogram assay for phospholipase activity based on a long-chain radioiodinatable phosphatidylcholine
Anal. Biochem.
333
289-295
2004
Naja naja
Manually annotated by BRENDA team
Satish, S.; Tejaswini, J.; Krishnakantha, T.P.; Gowda, T.V.
Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja Naja) venom
Biochimie
86
203-210
2004
Naja naja
Manually annotated by BRENDA team
Machiah, D.K.; Gowda, T.V.
Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera
Biochimie
88
701-710
2006
Naja naja
Manually annotated by BRENDA team
Shashidharamurthy, R.; Kemparaju, K.
A neurotoxic phospholipase A(2) variant: Isolation and characterization from eastern regional Indian cobra (Naja naja) venom
Toxicon
47
727-733
2006
Naja naja
Manually annotated by BRENDA team
Burke, J.E.; Dennis, E.A.
Phospholipase A2 biochemistry
Cardiovasc. Drugs Ther.
23
49-59
2009
Apis mellifera, Bitis gabonica, Bos taurus, Crotalus sp., Homo sapiens, Mus musculus, Naja naja, Oryza sativa, Rattus norvegicus, Sus scrofa, Protoparvovirus
Manually annotated by BRENDA team
Kamble, R.R.; Belgur, S.S.; Aladkatti, R.; Khazi, I.A.
Synthesis and evaluation of benzophenone oximes derivatized with sydnone as inhibitors of secretory phospholipase A2 with anti-inflammatory activity
Chem. Pharm. Bull.
57
16-21
2009
Naja naja, Daboia russelii, Trimeresurus malabaricus
Manually annotated by BRENDA team
Chethankumar, M.; Srinivas, L.
New biological activity against phospholipase A2 by Turmerin, a protein from Curcuma longa L
Biol. Chem.
389
299-303
2008
Naja naja
Manually annotated by BRENDA team
Burke, J.; Dennis, E.
Phospholipase A2 structure/function, mechanism, and signaling
J. Lipid Res.
50 Suppl
S237-S242
2009
Apis mellifera, Homo sapiens, Mus musculus, Naja naja
Manually annotated by BRENDA team
Dalm, D.; Palm, G.J.; Aleksandrov, A.; Simonson, T.; Hinrichs, W.
Nonantibiotic properties of tetracyclines: structural basis for inhibition of secretory phospholipase A2
J. Mol. Biol.
398
83-96
2010
Naja naja (P15445), Naja naja
Manually annotated by BRENDA team